newsfilter
← Latest News
Business Wire·

Rockwell Medical Regains Compliance with Nasdaq Listing Requirements

  • Rockwell Medical, Inc. (NASDAQ: RMTI) received notice from Nasdaq that it has regained compliance with the minimum bid price requirement under Listing Rule 5550(a)(2).
  • The Company maintained a minimum closing bid price of $1.00 per share or greater from July 1, 2026, to July 15, 2026.
  • Nasdaq has closed the matter regarding the bid price deficiency, \& Rockwell Medical is now in full compliance with all continued listing requirements.
  • The Company's stock remains listed \& traded on the Nasdaq Capital Market under the ticker "RMTI".
  • Rockwell Medical develops, manufactures, \& distributes hemodialysis products for dialysis providers worldwide.
  • The Company has been certified as a Great Place to Work for four consecutive years (2023-2026) \& named a Fortune Best Workplace in Manufacturing \& Production in 2024 \& 2025.
  • The press release includes forward-looking statements regarding anticipated benefits, such as maintaining its Nasdaq listing, which involve risks \& uncertainties.